-PTI NEW DELHI: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 per cent, Parliament was informed today. In a written reply in Lok Sabha, Minister of State, Chemicals and Fertilisers Mansukh L Mandaviya said the other four major countries from where India imports bulk drugs are Germany, the US, Italy and Singapore. India's import of active pharmaceutical ingredients (API) from China...
More »SEARCH RESULT
Total Matching Records found : 108
What's at stake in Hyderabad -Feroz Ali
-The Hindu India must counter Japan’s U.S.-style pressure at the RCEP talks and ensure affordable generic medicines Leaked texts are like leaked gases — you may never find the one responsible for it, but the mayhem caused by its release is hard to contain. Unsurprisingly, all public discussions on the Regional Comprehensive Economic Partnership (RCEP) are centred around leaked documents. As India negotiates the RCEP — a free trade agreement that looks...
More »New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus -Anoo Bhuyan
-TheWire.in The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIP-plus scenario. The chief negotiator for New Zealand, at the Asia trade pact talks in Hyderabad this week, made pointed reference to TRIPS-plus (Trade-Related Aspects of Intellectual Property Rights) provisions, saying that while the TRIPS agreement on intellectual property rights was sufficient, it was up to the countries to analyse whether...
More »US places India yet again on IPR 'priority watch' list -Amiti Sen
-The Hindu Business Line Frowns on India’s IP laws; New Delhi unfazed, says laws are TRIPS-compliant New Delhi: Expressing its disappointment with India for not making adequate changes in its IP laws and regulations despite announcing its National IPR policy last year, the US Trade Representative’s (USTR) office has once again placed the country in the ‘priority watch’ list in this year’s edition of the Special 301 report. “Almost a year after the...
More »Validation of India's drug patent policy -Latha Jishnu
-Down to Earth A high level UN panel on Access to Medicines wants members to make full use of TRIPS flexibilities to protect public health If ever India needed a clear endorsement of its laws on intellectual property rights (IPRs) and their application in meeting public health priorities, it has come from the highest quarters. The report of the UN Secretary General’s High Level Panel (HLP) on Access to Medicines has, directly...
More »
